Dr. Ayaan El-Tayeb, PharmD, MSc

Senior Clinical Research Scientist, Department of Therapeutic Development
Co-Director, Precision Medicine Research Unit, Cairo Global Health Institute

Professional Summary

Dr. Ayaan El-Tayeb is an accomplished clinical pharmacologist and researcher specializing in drug development, clinical trial coordination, and therapeutic response evaluation. With over 15 years of experience, Dr. El-Tayeb has worked across industry and academia, bridging the gap between research and regulatory frameworks to ensure safe and ethical practices in global trials.

Experience

• PharmD, Ain Shams University, Egypt

• MSc in Clinical Research, University of Manchester, UK

• Certified Clinical Trials Specialist (CCTS) – ACRP

Academic Qualifications

• Former Section Editor, Journal of Experimental Therapeutics

• Peer Reviewer for The Lancet, BMJ Open, and Nature Medicine

• Member, European Clinical Research Infrastructure Network (ECRIN)

Research Focus

• Pharmacovigilance & therapeutic risk profiling

• Trial design for emerging markets

• Patient-centered outcomes in chronic disease trials

• Digital therapeutics integration in trial protocols

Editorial & Scientific Contributions

• Associate Editor, Journal of Therapeutic Risk Management

• Reviewer, Clinical Trials and BMJ Therapeutics

• Contributor to WHO clinical trial standards review group

Recent Work

Associate Editor

Mogito Open Access Journal of Clinical Trials & Therapeutics (MJCTT)

• Coordinated a 12-country trial on biologic therapy for autoimmune disorders

• Developed a clinical dashboard for real-time patient response tracking

• Published over 50 articles and white papers on therapeutic trial strategies

Commitment to MJCTT

• "My editorial goal is to elevate MJCTT as a cornerstone of globally inclusive, scientifically rigorous, and ethically responsible clinical research."

About (MJCTT)

Mogito Open Access Journal of Clinical Trials & Therapeutics (MJCTT) is a peer-reviewed, international, open access journal committed to advancing research in clinical trials, experimental therapeutics, and evidence-based medical innovation. As a key title under the Medicine & Clinical Research category of the Mogito Open Access Journals platform, MJCTT serves as a global forum for academics, clinicians, and industry experts to share high-impact, original findings and critical evaluations that shape the future of therapeutic strategies and patient care.